Company · CIK 0001971387 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Liminatus Pharma, Inc. · LIMN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 JForm 4 → | Jul 14, 5:46 pm EDT | Valetudo Therapeutics LLC +110% Owner | 3,448,926 | — | — | 5,244,351 | — | late |
| Jun 24, 2026 JForm 4 → | Jul 6, 4:59 pm EDT | Valetudo Therapeutics LLC +110% Owner | 4,373,603 | — | — | 1,795,803 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.